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Abstract. 
 
Bone has an enormous capacity for growth, 
regeneration, and remodeling. This capacity is largely 
due to induction of osteoblasts that are recruited to the 
site of bone formation. The recruitment of osteoblasts 
has not been fully elucidated, though the immediate en-
vironment of the cells is likely to play a role via cellÐ
matrix interactions. We show here that heparin-binding 
growth-associated molecule (HB-GAM), an extracellu-
lar matrixÐassociated protein that enhances migratory 
responses in neurons, is prominently expressed in the 
cell matrices that act as target substrates for bone for-
mation. Intriguingly, N-syndecan, which acts as a recep-
tor for HB-GAM, is expressed by osteoblasts/osteo-
blast precursors, whose ultrastructural phenotypes 
suggest active cell motility. The hypothesis that HB-
GAM/N-syndecan interaction mediates osteoblast re-
cruitment, as inferred from developmental studies, was 
tested using osteoblast-type cells that express N-synde-
can abundantly. These cells migrate rapidly to HB-
GAM in a haptotactic transfilter assay and in a migra-
tion assay where HB-GAM patterns were created on 
culture wells. The mechanism of migration is similar to 
that previously described for the HB-GAMÐinduced 
migratory response of neurons. Our hypothesis that 
HB-GAM/N-syndecan interaction participates in regu-
lation of osteoblast recruitment was tested using two 
different in vivo models: an adjuvant-induced arthritic 
model and a transgenic model. In the adjuvant-induced 
injury model, the expression of HB-GAM and of
N-syndecan is strongly upregulated in the periosteum 
accompanying the regenerative response of bone. In 
the transgenic model, the HB-GAM expression is 
maintained in mesenchymal tissues with the highest ex-
pression in the periosteum. The HB-GAM transgenic 
mice develop a phenotype characterized by an in-
creased bone thickness. HB-GAM may thus play an im-
portant role in bone formation, probably by mediating 
recruitment and attachment of osteoblasts/osteoblast 
precursors to the appropriate substrates for deposition 
of new bone. 
Key words: heparin-binding growth-associated mole-
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B
 
one
 
 is characterized by an extraordinary capacity for
growth, regeneration, and remodeling throughout
life. This capacity has been largely attributed to a
series of diffusible growth and differentiation factors that
lead to formation of bone by inducing differentiation of
osteoblasts (Rosen and Thies, 1992; Kingsley, 1994; Bone-
wald, 1996). The process of new bone formation can be di-
vided into several stages. At an initial stage, precursors of
osteoblasts are recruited to the site for osteoid deposition.
After arriving, these cells differentiate into fully func-
tional, osteoid-producing osteoblasts (Bonewald, 1996).
To form appropriate shape and mass of future bone, the
recruitment of the osteoblast precursors must be precisely
regulated.
Osteoblasts/osteoblast precursors are shown to be re-
cruited by chemotactic signals via diffusible factors like
TGF-
 
b
 
s (Bonewald, 1996), at least to the vicinity of their
destinations. At the stage of osteoid deposition, osteo-
blasts are always found attached to substrates, although
the target substrates may vary in different locations and at
different developmental stages. For example, the mineral-
ized cartilage during endochondral ossification, the bone
surface during appositional ossification, and the head epi-
 
Address all correspondence to Shinji Imai, M.D., Ph.D., Department of
Anatomy, Shiga University of Medical Science, Setatsukinowa-cho, Otsu-
shi, Shiga-ken, 520-2192, Japan. Tel.: 81-77-548-2136. Fax: 81-77-548-2139.
E-mail: simai@belle.shiga-med.ac.jp
  
The Journal of Cell Biology, Volume 143, 1998 1114
 
thelia during intramembranous ossification of the skull
serve as the substrates for osteoid deposition. This evi-
dence leads to the hypothesis that the osteoblast recruit-
ment and attachment to their target substrates may be
mediated by contact-dependent signal(s) provided by yet
unidentified molecule(s) immobilized in the target sub-
strates.
Heparin-binding growth-associated molecule (HB-GAM)
 
1
 
(also designated as pleiotrophin) is an extracellular ma-
trixÐassociated protein rich in lysine and cysteine residues
(Li et al., 1990; Merenmies and Rauvala, 1990). HB-GAM
is rapidly secreted from cells upon cleavage of its classic-
type secretion signal (Raulo et al., 1994). The sequence of
HB-GAM is conserved more than 95% in the human, rat,
bovine, and chicken (Li et al., 1990; Hulmes et al., 1993)
and shares 50% homology with midkine (Tomomura et
al., 1990). HB-GAM was first isolated from developing rat
brain (Rauvala, 1989), but it also occurs in many nonneu-
ronal tissues during embryonic development (Mitsiadis et
al., 1995). During development, the expression of HB-GAM
is strictly regulated both in neuronal and nonneuronal tis-
sues. High expression levels of HB-GAM are found in fi-
ber pathways of the developing nervous system (Rauvala
et al., 1994) and in basement membranes outside of the
nervous system (Mitsiadis et al., 1995). Interestingly, a
cDNA clone having the same sequence as HB-GAM was
isolated from a murine osteosarcoma cell line MC3T3, and
the protein was termed as osteoblast stimulating factor-1
(OSF-1) (Tezuka et al., 1990). Up to 3.5 mg/kg of HB-GAM/
OSF-1 could be isolated from bovine bone (Zhou et al.,
1992), and such a high amount has been found in no other
tissue except the developing brain (Rauvala, 1989). How-
ever, the function of HB-GAM in bone tissue remains to
be determined.
Syndecans are sequence-related transmembrane hepa-
ran sulfate proteoglycans sharing a conserved intracellular
domain but having structurally heterogeneous extracellu-
lar domains (for reviews see Bernfield et al., 1992; Carey,
1997). Up to now, four different members of syndecans
have been cloned (Marynen et al., 1989; Saunders et al.,
1989; Carey et al., 1992; David et al., 1992), and expression
of each member is strictly regulated in tissue typeÐ and de-
velopmental stageÐspecific manners (Carey, 1997). For in-
stance, syndecan-3 was originally cloned from rat Schwann
cell cDNA library and has been named as N-syndecan be-
cause of its exclusive expression in the developing nervous
system (Carey et al., 1992; Carey, 1997). In the developing
brain, expression of N-syndecan shows a clear-cut spa-
tiotemporal relation to that of HB-GAM (Nolo et al.,
1995; A. Kinnunen et al., 1998), an extracellular ligand for
N-syndecan (
 
K
 
d
 
 
 
5 
 
0.6 nM) (Raulo et al., 1994). The
ectodomain of N-syndecan binds to matrix-associated HB-
GAM by its heparan sulfate chains (iduronic acid-2-0-sul-
fates are implicated in the binding), although the protein
part also affects the binding (Kinnunen et al., 1996). Very
recent biochemical and cell biological studies have shown
that the conserved cytosolic domain of N-syndecan binds
a protein complex containing src-family tyrosine kinases
(pp60-src and fyn) and the src-substrate cortactin (T. Kin-
nunen et al., 1998). Binding of HB-GAM to N-syndecan
leads to phosphorylation and activation of src followed
by cortactin phosphorylation (T. Kinnunen et al., 1998).
Phosphorylation of cortactin is known to modulate its
F-actin cross-linking activity (Hung et al., 1997), which
may lead to cytoskeletal reorganization pertinent to cell
motility. Although it appears clear that N-syndecan func-
tions as an HB-GAM receptor in neurite extension, the
possible role of the HB-GAM/N-syndecan interaction out-
side of the nervous system has not been previously ad-
dressed.
In the present study, we demonstrate the presence of
N-syndecan in osteoblasts/osteoblast precursors and the
presence of HB-GAM in their target substrates during de-
velopment and regeneration of rat bone. The spatiotem-
poral relationship of N-syndecan and HB-GAM suggests
that interaction of this receptor-ligand pair may play a role
in the osteoblast recruitment and attachment to their tar-
get substrates. We then use several osteoblast-type cells, in
which the present study demonstrates endogenous N-syn-
decan as abundantly as in the developing rat brain. Osteo-
blast-type cells are shown to be recruited and attached to
HB-GAM when presented as an insoluble substrate.
Lastly, we produce transgenic mice that maintain an ele-
vated level of HB-GAM, which is normally downregulated
after skeletal development. The maintained high level of
HB-GAM expression leads to an increased bone volume,
presumably by maintaining an elevated osteoblast recruit-
ment and attachment to their target substrate.
 
Materials and Methods
 
N-Syndecan and Recombinant HB-GAM 
 
Recombinant HB-GAM was produced with the aid of baculovirus in
 
Spodopteria frugiperda
 
 cells and purified to apparent homogeneity from
the culture medium as described previously (Raulo et al., 1992). N-synde-
can was isolated as previously described (Raulo et al., 1994). Alcian blue-
silver staining that detects both proteins and proteoglycans was used in
combination with SDS-PAGE to detect fractions that contain N-syn-
decan.
 
Antibodies to N-Syndecan and HB-GAM 
 
Affinity-purified antibodies against recombinant HB-GAM were pro-
duced in rabbit as previously described (Raulo et al., 1992) and affinity-
purified as previously described (Rauvala, 1989). These antibodies have
been characterized by Western blotting (Raulo et al., 1992), and their
specificity against HB-GAM has been verified in an immunohistochemi-
cal context (Peng et al., 1995). Affinity-purified antibodies against a syn-
thetic peptide corresponding to the NH
 
2
 
-terminal extracellular moiety of
rat N-syndecan (Carey et al., 1992) were produced and verified by West-
ern blotting and immunohistochemistry (Raulo et al., 1994; Nolo et al.,
1995).
 
Histological Procedures
 
All the animals used in the study were perfusion-fixed with 4% parafor-
maldehyde and 0.5% glutaraldehyde in 0.1 M phosphate buffer (PB), except
for embryos that were immersion-fixed with the same fixative. Five to six
serial cryostat sections (40 
 
m
 
m thick) were cut for each animal. Three to
four sections were handled for light microscopy, while the remaining two
to three sections were reserved for electron microscopy (EM) after immu-
nostaining. Replacement of primary antibodies with nonspecific rabbit
IgG served as a negative control. After avidin-biotin-peroxidase complex
reaction (Vector Laboratories, Burlingame, CA), peroxidase label was de-
veloped in 0.04% 3,3-diamine-benzidine tetrahydrochloride (DAB) with
 
1. 
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 HB-GAM, heparin-binding growth-
associated molecule; PP1, pyrazolopyrimidine 1. 
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nickel enhancement (0.3% nickel ammonium sulfate). Thus, positive
staining produces blue color on light microscopy and aggregated intense
electron-density on EM. Detailed procedures are described elsewhere
(Imai et al., 1997).
 
Immunoelectron Microscopy
 
The immunostained sections reserved for EM were postfixed with 1% os-
mium tetroxide for 1 h and dehydrated in ethanol series. The sections
were flat-embedded in Epon medium and coverslipped on glass slides
coated with silicon. Light microscopic observation was made at this point
to select areas to be examined electron-microscopically. Ultrathin sections
(60 nm) were stained with uranyl acetate and lead citrate and were exam-
ined by a transmission electron microscope (Acceleration voltage: 60
KeV; model Joel 1200; Joel, Tokyo, Japan).
 
Probes and In Situ Hybridization
 
A 1.8-kb fragment of N-syndecan cDNA, corresponding to base pairs 67Ð
1867 and containing the full coding region of the mRNA (Carey et al.,
1992), was used for preparation of N-syndecan probe. A 1.25-kb cDNA
containing the whole coding sequence of HB-GAM (Merenmies and Rau-
vala, 1990) was used to prepare HB-GAM probe. Digoxigenin-labeled
single-stranded sense and anti-sense RNA probes were generated as pre-
viously described (Szabat and Rauvala, 1996). 10 serial cryostat sections
(7 
 
m
 
m thick), which topographically correspond to the immunostained
sections, were cut and mounted on glasses. In situ hybridization was per-
formed using a modified protocol of Wilkinson (1992) and is described
elsewhere (Nolo et al., 1995).
 
Cell Culture and Cell Types
 
Rat osteoblast-type cells, UMR-106 (ATCC CRL-1661), and human os-
teoblast-type cells, Saos-2 (ATCC HTB-85), U-2 OS (ATCC HTB-96),
and KHOS/NP (ATCC CRL-1544), were recently purchased from the
American Type Culture Collection (ATCC; Rockville, MD). Cells were
freshly prepared for the assays in media recommended by the ATCC
(UMR-106: DME, Saos-2, and U-2 OS: McCoyÕs 5A medium, KHOS/NP:
minimal essential EagleÕs medium) supplemented with 10% FCS, 100 U/ml
penicillin G, and 100 
 
m
 
g/ml streptomycin. For comparison, 3T3 fibroblast-
type cells and N18 neuroblastoma cells were used as control cells. Cells
were harvested by trypsin and EDTA treatment and were recovered in
suspension with 10% FCS-containing media for 1.5 h before using in
assay.
 
RNA Preparation and Northern Blot Analysis
 
To characterize the used osteoblast-type cells in terms of N-syndecan ex-
pression, Northern analysis for rat N-syndecan RNA was performed. To-
tal RNA was prepared from UMR-106, N18, and 3T3 cells by lysis with
guanidinium isothiocyanate, phenol extraction, and ethanol precipitation
using RNeasyª Total RNA Kits (QIAGEN GmbH, Hilden, Germany).
RNA prepared from rat perinatal brain served as control (Nolo et al.,
1995). The RNA was quantified spectrophotometrically, and 10 
 
m
 
g of to-
tal RNA was prepared for each lane. The RNA was electrophoresed in
1.2% agaroseÐ7% formaldehyde gel and transferred to nylon filter. A 200-
bp fragment of rat N-syndecan cDNA (Nolo et al., 1995) was labeled with
 
32
 
P Ready-to-go DNA labeling kit (Amersham Pharmacia Biotek, Upp-
sala, Sweden). After hybridization and washing, the filter was subject to
autoradiography.
 
Isolation of the HB-GAMÐbinding Fraction from
UMR-106 Cells
 
To characterize the HB-GAMÐbinding components from UMR-106, the
cells were extracted with 50 mM octyl glucoside in ice-cold PBS containing
1 mM PMSF. HB-GAM affinity column was prepared by coupling 5 mg of
the recombinant HB-GAM to a 1-ml NHS-activated HI-TRAP column
(Amersham Pharmacia Biotek). The extracts were centrifuged at 40,000 
 
g
 
for 0.5 h, and the supernatants were passed through the column that had
been equilibrated with 50 mM octyl glucoside. The column was then
eluted with a 0.15Ð2.0 M linear gradient of NaCl. One-column volume
fractions were collected, run on 4Ð15% SDS-PAGE, and stained with al-
cian blueÐsilver nitrate. The apparent molecular mass of the proteoglycan
core protein was estimated after nitrous acid depolymerization. HB-
GAMÐbinding fractions from perinatal rat brain served as positive control
and were prepared as previously described (Raulo et al., 1994).
 
Western Blot Analysis of the HB-GAMÐbinding 
Fraction from UMR-106
 
To identify that the HB-GAMÐbinding fraction from UMR-106 is
N-syndecan, the samples were transferred on Immobilon
 
 
 
P
 
 
 
(Millipore,
Molsheim, France) in 10 mM CAPS, pH 9.0, for 2 h at 70 V. Affinity-puri-
fied polyclonal antibodies against the NH
 
2
 
-terminal synthetic peptide of
N-syndecan were applied, and alkaline phosphataseÐconjugated second-
ary antibodies were used for the detection.
 
Transfilter Migration Assay
 
Haptotactic migratory response to HB-GAM was studied for all the used
osteoblast-type cells (i.e., rat osteoblast-type cells, UMR-106; and human
osteoblast-type cells, Saos-2, U-2 OS, and KHOS/NP). The assay was car-
ried out in Transwell chambers (Corning Costar, Cambridge, MA). The
chamber is divided by a polycarbonate microporous filter (15 
 
m
 
m thick,
pore size 8 
 
m
 
m), and the purified recombinant HB-GAM was coated to
the lower surface of the filter at doubling concentrations from 0.025 to
50.0 
 
m
 
g/ml overnight at 4
 
8
 
C. The filter was then thoroughly washed with
water and dried in laminar flow hood. The chamber was filled with the
FCS-free medium containing 1 mg/ml BSA 30 min before adding cells.
Cells were placed in the upper chamber at 
 
z
 
1.0 
 
3 
 
10
 
5
 
 cells/cm
 
2 
 
and cul-
tured for 4 h. After fixing with methanol for 15 min, staining with 0.05%
toluidine blue, and removal of the cells from the upper surface of the fil-
ter, cells that had migrated and attached to the lower surface were exam-
ined under a light microscope. Five fields per filter were counted for cell
number (1 field 
 
5 
 
1/160 of entire surface of filter). Filters coated with 20
 
m
 
g/ml of nonspecific rat IgG or 10 mg/ml of BSA served as controls.
 
Inhibition of Osteoblast Recruitment by Adding Soluble 
HB-GAM and N-Syndecan
 
To test that the cell recruitment was induced by binding of cell surface
N-syndecan and substrate-bound HB-GAM, the binding was competed by
adding soluble forms of N-syndecan or HB-GAM to the medium. Dou-
bling concentrations of soluble HB-GAM (from 5 to 20 
 
m
 
g/ml) or soluble
N-syndecan (from 1 to 4 
 
m
 
g/ml) were added to the cell suspension 30 min
before plating the cells. UMR-106 cells were plated on the filter, the lower
side of which was coated with 10 
 
m
 
g/ml HB-GAM. The number of cells
that migrated was counted as described above.
 
Inhibition of Osteoblast Recruitment by Adding 
Tyrosine Kinase Inhibitors
 
A possible involvement of tyrosine phosphorylation in HB-GAMÐ
induced osteoblast recruitment was tested using inhibitors of protein tyro-
sine kinases. Benzoquinoid ansamycin (herbimycin A), a widely used gen-
eral inhibitor of protein tyrosine kinases (Migita et al., 1994), and
pyrazolopyrimidine 1 (PP1), a recently defined specific inhibitor of src-
type tyrosine kinases (Hanke et al., 1996), were added to the cell suspen-
sion 10 min before plating cells to inhibit N-syndecanÐmediated intracel-
lular phosphorylation. Then, cells were subject to the transfilter assay
using 10 
 
m
 
g/ml of substrate-bound HB-GAM.
 
Osteoblast Recruitment from Denatured HB-GAM to 
Intact HB-GAM
 
Since cells may attach nonspecifically to polycationic proteins, the follow-
ing cell recruitment assay was designed to show that the three-dimension-
ally intact structure of HB-GAM is pertinent to the osteoblast recruit-
ment. The purified recombinant HB-GAM was coated to chamber slides
(Lab-tek: Nunc, Inc., Naperville, IL) at different concentrations at 0, 0.1,
0.5, 1, 5, 10, 25, and 50 
 
m
 
g/ml overnight at 4
 
8
 
C. The chambers were washed
with water and dried in a laminar flow hood, and electron microscopy
grids were placed over the coated HB-GAM. The chambers were then
UV-irradiated (model UV Stratalinker TM 2400, Stratagene, La Jolla,
CA; wave length 254 nm) for 1 h. After removal of the grids, the chamber
was thoroughly washed with water and filled with the FCS-free media
containing 1 mg/ml BSA 30 min before plating the cells. The UMR-106
cells were plated at 1.25 
 
3 
 
10
 
5
 
 cells/cm
 
2
 
 and cultured in the FCS-free me-
dium. Chamber slides coated with 20 
 
m
 
g/ml of nonspecific rat IgG or 10 
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mg/ml of BSA served as control substrates. N18 and 3T3 cells, which are
shown to be N-syndecan negative in the present study, served as negative
control cells.
 
A Model of Postarthritic Periosteal Ossification
 
The study included 25 male Wistar-Lewis rats, aged 7 wk (body weight:
230Ð250 g). Postarthritic, periosteal ossification has been characterized in
an adjuvant-induced arthritic model (Imai et al., 1997). In brief, 15 rats re-
ceived intradermal injection of 0.05 ml suspension of FreundÕs complete
adjuvant (cell wall fragments of heat-killed mycobacterium butylicum; 3
mg/g body weight; Difco Laboratories, Detroit, MI) in paraffin oil into the
tail base. The remaining 10 animals, serving as controls, received the par-
affin oil alone. Signs of inflammation in the hindpaw appeared by 7 d after
inoculation. Apparent acute inflammation subsides, and the periosteum
becomes proliferated during the second week. The proliferated perios-
teum mineralizes during the third week (Imai et al., 1997). The animals
were killed 7, 10, 14, 21, and 28 d after inoculation of the adjuvant or vehi-
cle (three animals/arthritic group and two animals/control group). Immu-
nohistochemistry and immuno-EM for HB-GAM and N-syndecan were
performed on the ankle samples.
 
Production of Transgenic Mice
 
HB-GAM cDNA (Merenmies and Rauvala, 1990) was cloned into a
BamHI restriction site in pHBApr-1-neo vector (Gunning et al., 1987).
pHBApr-1-neo contains the promoter and the first intron from human
 
b
 
-actin gene and SV-40Ðpolyadenylation signal. The expression cassette
was removed from the plasmid by digestion with EcoRI and NdeI, sepa-
rated by agarose gel electrophoresis, and purified. Fertilized eggs from
FVB/NIH and FlxNMRI mice were used for microinjection. Founder ani-
mals were screened by Southern blotting from tail biopsies. Founder ani-
mals were bred with FVB/NIH mice.
 
Western Blot Analysis of the Transgenic Mice
 
Tissue samples from transgenic and nontransgenic littermates were dis-
sected, minced with scissors, and weighed. 1 ml sample buffer (60 mM
Tris, pH 6.8, 8% glycerol, 1.8% SDS, 4.5% 
 
b
 
-mercaptoethanol) was added
per 100 mg tissue, and the tissue was solubilized by boiling for 10 min.
Samples were centrifuged and 10 or 20 
 
m
 
l of the supernatant (correspond-
ing to 1 or 2 mg of tissue weight) was loaded on SDS-PAGE. Proteins
were transferred to nitrocellulose membrane. HB-GAM was detected by
affinity-purified antibodies against the NH
 
2
 
-terminal synthetic peptide of
HB-GAM (Rauvala, 1989).
 
Histopathologic and Histomorphometric Analysis of 
Transgenic Mice
 
Gross appearance of the skeletons was evaluated after maceration in
potassium hydroxide and removal of the soft tissue. Immunohistochemical
localization of HB-GAM was studied using longitudinal and cross-sec-
tional sections of femora and humeri of 1-yr-old animals (two transgenic
and two nontransgenic animals). Histomorphometric analyses, following
the recommended procedures and nomenclature (Parfitt, 1987), were
conducted on seven transgenic and nine nontransgenic animals using
computer-assisted image analyzer (model Image-Pro Plus; Media Cyber-
netics, Los Angeles, CA).
 
Results
 
Expression of HB-GAM and N-Syndecan during 
Prenatal Development of Bone 
 
HB-GAM was intensely expressed in the matrix of the de-
veloping cartilage (Fig. 1 
 
a
 
), which acts as a template for
endochondral bone formation (Marks and Hermey, 1996).
Little if any expression of N-syndecan was detected before
beginning of ossification (Fig. 1 
 
b
 
). HB-GAM persisted in
the matrix of the mineralized cartilage (Fig. 1 
 
c
 
), onto
which osteoblasts deposit osteoid (Marks and Hermey,
1996; Scammell and Roach, 1996). N-syndecanÐexpressing
cells were localized in the zone of the mineralized cartilage
(Fig. 1 
 
d
 
). The localization of the two molecules thus over-
lapped in the zone of the mineralized cartilage (Fig. 1 
 
c
 
, 
 
ar-
rowheads
 
, and Fig. 1 
 
d
 
, 
 
arrows
 
). The overlapping expres-
sion of the two molecules was maintained while the
frontier of the ossification advanced toward the ends of
the cartilage template, i.e., N-syndecanÐexpressing cells
appeared to trace the mineralized cartilage, where HB-
GAM is abundantly expressed. On the other hand, N-syn-
decan was not expressed in the anatomical regions where
formation of bone tissue had been already completed.
These light microscopic localizations of N-syndecanÐ
expressing cells suggest that N-syndecan is expressed by
the osteoblast lineage cells that are migrating toward the
target matrix. As for the cellular source of HB-GAM, im-
munolocalization of HB-GAM and in situ hybridization of
its mRNA (see below) suggest that chondrocytes supplies
it to the cartilage matrix.
Localization of the mRNAs, in turn, did not overlap.
HB-GAM mRNAÐpositive cells were localized within the
unmineralized cartilage matrix, whereas N-syndecan mRNAÐ
positive cells were localized within the mineralized carti-
lage and mineralized bone (Fig. 1, 
 
e
 
 and 
 
f
 
). N-syndecan im-
muno-EM of the mineralized cartilage (Fig. 1 
 
f
 
, rectangle
 
g
 
) showed numerous N-syndecanÐexpressing cells (Fig. 1
 
g
 
, 
 
ch-b
 
) that were distinct from the hypertrophied chon-
drocytes (Fig. 1 
 
g
 
, 
 
ch-a
 
). Immuno-EM of the mineralized
bone (Fig. 1 
 
f
 
, rectangle 
 
h
 
) showed that N-syndecan was
expressed by a group of cells, the ultrastructural pheno-
types of which were not of blood vessels, osteoclasts, or
macrophages but were suggestive of an active motility
with the spindle-shaped cell somas and well-developed cell
processes (Fig. 1 
 
h
 
). These cells were often seen in the
channels between the trabeculae of the mineralized bone.
Based on their ultrastructural features, N-syndecan may
be expressed by the osteoblast lineage cells that are mi-
grating before adhesion to their target matrix.
 
Expression of HB-GAM during Postnatal Development 
of Bone
 
The postnatal growth of bone involves numerous anatomi-
cal sites of new bone formation. The metaphyseal part of
the cartilage template remains as the growth plate that is
responsible for the postnatal elongation of long bone. HB-
GAM was abundantly expressed in the growth plate (Fig.
2 
 
a
 
), which remains throughout life in rodents. The phy-
seal part of the cartilage gives rise to two types of cartilage,
i.e., the outer portion of the cartilage becomes articular
cartilage, and the inner portion of the cartilage provides a
substrate for osteoblast recruitment by forming a second-
ary ossification center. HB-GAM was intensely expressed
in the cartilage matrix that forms the hollow for the sec-
ondary ossification center, with the chondrocytes being
presumptive cellular source of HB-GAM. In contrast, HB-
GAM was not expressed in the outer portion that becomes
the articular cartilage in future (Fig. 2 
 
a
 
).
The woven bone that is formed to create the initial
shape of bone during prenatal life is continuously resorbed
by osteoclasts and macrophages and finally disappears
during early postnatal life. In turn, the space created by re- 
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sorbing the woven bone is replaced by lamellar bone,
which continues to grow further until adulthood. HB-
GAM was expressed selectively by the osteocytes of the
lamellar bone, whereas it was hardly expressed by those of
the woven bone (Fig. 2, 
 
bÐd
 
). HB-GAM was detected in
the matrix surrounding the osteocytes (Fig. 2 
 
e
 
, 
 
double ar-
rows
 
) and in the canaliculi of the osteocytes (Fig. 2 
 
e
 
, 
 
ar-
row
 
). Most interestingly, HB-GAM was distributed on the
surface of lamellar bone, where the growth of bone takes
place by adding new bone. Thus, the osteocytes of the
lamellar bone may prepare the bone surface as an osteo-
conductive surface by distributing HB-GAM through the
network of bone canaliculi. After skeletal development,
however, expression of both HB-GAM and N-syndecan is
downregulated (see below for details of the periosteal ex-
pression). Taken together, HB-GAM is expressed in the
various anatomical sites where osteoblasts are recruited
and attached for the postnatal bone formation.
 
Osteoblast Recruitment Mediated
by the N-Syndecan/HB-GAM Interaction
 
To test the hypothetical osteoblast recruitment induced by
HB-GAM, we first performed a haptotactic assay using
several osteoblast-type cells. All of the studied osteoblast-
type cells rapidly migrated to HB-GAM in a dose-depen-
dent manner, whereas the control cells, N18 and 3T3 cells,
did not respond to HB-GAM (Fig. 3 
 
A
 
). Thus, the migra-
tion-enhancing effect of HB-GAM appears to be a general
finding in the case of osteoblast-type cells (osteogenic sar-
coma-derived cell lines).
Since N-syndecan appears to be expressed by migratory
cells of the osteoblast lineage in vivo (Fig. 1, 
 
g
 
 and 
 
h
 
), we
further investigated the possible functional role of N-syn-
decan using rat osteoblastic cells (UMR-106 cells) and the
control cells (N18 and 3T3 cells). Northern analysis showed
a high expression level of N-syndecan mRNA in UMR-
Figure 1. Expression of HB-GAM and
N-syndecan in the developing rat bone
(immunodetection for the protein, aÐd; in
situ hybridization for mRNA, e and f; im-
munoelectron microscopy for N-syndecan,
g and h; E, embryonic day). (a) Abundant
expression of HB-GAM in the cartilage
templates. (b) No expression of N-synde-
can in the cartilage templates at E16 (the
same magnification as in a). (c) HB-GAM
expression persisting in the mineralized
cartilage, the structure of which is con-
ceivable by the enlarged lacunae of the
chondrocytes (arrowheads). (d) N-syndecan
expression by the cells dispersed in the
mineralized cartilage (arrows; the same
magnification as in c). (e) Selective expres-
sion of HB-GAM mRNA by the chondro-
cytes in the cartilage matrix (cm). (f) Selec-
tive expression of N-syndecan mRNA by
the cells in the mineralized cartilage (mc)
and mineralized bone (the same magnifi-
cation as in e; the rectangles g and h rep-
resent the regions of panels g and h). (g)
N-syndecan is localized on the surface of
the cell (arrowheads; ch-b), the phenotype
of which is distinct from a hypertrophied
chondrocyte (ch-a) (the rectangle indicates
the inset). (h) N-syndecan is expressed by
the cells in the mineralized bone (arrow-
heads; the rectangle indicates the inset).
The ultrastructural phenotype of the cells
suggest an active motility with well-devel-
oped cell processes. hm, humerus; rd, ra-
dius; ul, ulna; mb, mineralized bone. Bars:
(a and e) 500 mm; (c) 1,250 mm; (g) 10 mm;
(h) 8 mm.The Journal of Cell Biology, Volume 143, 1998 1118
106. The expression level was similar to or even higher
than that of the perinatal brain (Fig. 3 B). Affinity chro-
matography showed that UMR-106 cells express a major
HB-GAMÐbinding protein with a molecular mass similar
to that found in the perinatal brain, and this protein was
identified as N-syndecan by Western blotting (Fig. 3 C).
All members of the syndecan family have a conserved pro-
tease-susceptible site at the extracellular juxtaposition to
the transmembrane domain (Carey, 1997), and treatment
of the UMR-106 with trypsin (0.01% wt/vol, for 5 min)
clearly abolished N-syndecan immunostaining (Fig. 3 D).
Taken together, the rat osteoblastic cells, UMR-106, ex-
press N-syndecan as their major HB-GAMÐbinding pro-
tein on the cell surface. In contrast, the control cells that
did not respond to HB-GAM were found to be N-synde-
can negative (Fig. 3 B). Thus, the responsiveness to HB-GAM
in the transfilter assay appears to depend on the presence
of N-syndecan.
The recruitment of UMR-106 cells was competed by
adding a soluble form of HB-GAM or N-syndecan into the
cell suspension (Fig. 3 E, a), suggesting that the cell re-
cruitment was mediated by binding of the cell surface
N-syndecan and the substrate-bound HB-GAM. The cell
recruitment was also inhibited by adding the inhibitors of
tyrosine kinases into the medium (Fig. 3 E, b), suggesting
that the cytoskeletal reorganization pertinent to the
HB-GAMÐinduced cell recruitment is mediated by ty-
rosine phosphorylation of intracellular components.
Osteoblast Recruitment to the Intact HB-GAM from 
the Denatured HB-GAM
Since cells may attach nonspecifically to polycationic pro-
teins, another cell recruitment assay was designed. Irradia-
tion with UV light has a protein-denaturing effect, but it is
not expected to destroy the polycationic nature of the pro-
tein. UV-irradiation has been previously used to create
patterned substrates from laminin (Hammerback et al.,
1985) and from HB-GAM (Rauvala et al., 1994). UMR-
106 cells were clearly recruited to the intact HB-GAM
from the UV-irradiated HB-GAM at the concentration of
50 mg/ml (Fig. 4, bÐd), suggesting that the intact molecular
structure of HB-GAM is a prerequisite for the recruitment
of the UMR-106 cells. Cell migration was inactive at lower
concentration of HB-GAM, and the cells did not migrate
at all when the substrate was not previously coated with
HB-GAM (data not shown). The N-syndecanÐnegative
control cells, N18 neuroblastoma cells and 3T3 fibroblasts,
were not recruited to the intact HB-GAM (data not
shown).
Expression of HB-GAM and N-Syndecan during 
Postarthritic Periosteal Ossification
Normal adult rat bone hardly expresses HB-GAM (Fig. 5)
or N-syndecan (Fig. 5 c, also see the rectangle in Fig. 5 a
for orientation). To study possible participation of both
molecules in regenerative ossification of adult bone, we
used a postarthritic ossification model. Intracutaneous in-
oculation of FreundÕs adjuvant induces a systemic autoim-
mune-type arthritis z10 d after inoculation (day 10). After
the arthritic damage, the periosteum goes through a direct
intramembranous ossification (Fig. 5, j and m, rectangles)
(Imai et al., 1997).
HB-GAM and N-syndecan were upregulated in a site-
and time-specific manner during the process. Ultrastruc-
turally, HB-GAM was first seen around the osteocytes on
day 7, and the osteocytes appeared to distribute HB-GAM
into the osteocytic lacunae (Fig. 5 d). Light microscopi-
cally, numerous HB-GAMÐexpressing osteocytes were
noted within the damaged bone (Fig. 5 e). At this stage,
however, N-syndecan expression was not detected (Fig. 5 f).
On day 10, an increased number of HB-GAMÐexpress-
ing osteocytes was noted in the damaged bone (Fig. 5 h).
In addition to osteocytic lacunae, HB-GAM was noted on
the numerous osteocytic processes adjacent to the dam-
aged bone surface (Fig. 5 g). The surface of the damaged
bone became immunoreactive to HB-GAM in a similar
manner to that found during the postnatal growth of bone
(Fig. 5 h, compare to Fig. 2 e). Osteocytes are extensively
connected with bone surface via their cell processes that
form a network within the bone (Nijweide et al., 1996);
thus the osteocytes may have distributed HB-GAM to the
bone surface. Because of accumulation of induced osteo-
blasts, the periosteum thickens during the arthritic damage
(Fig. 5 j) and ossifies thereafter (Fig. 5 m) (Imai et al.,
1997). The thickened periosteum became immunoreactive
to N-syndecan for the first time on day 10 (Fig. 5 i).
On day 14, HB-GAM was richly expressed in the thick-
ened periosteum (Fig. 5 k), and the expression pattern of
N-syndecan was similar to that of HB-GAM (Fig. 5 l). HB-
GAM and N-syndecan were downregulated at the stage of
Figure 2. Expression of HB-GAM during postnatal development
of bone. (a) HB-GAM is intensely expressed in the secondary os-
sification center, in the growth plate, and in the periosteum (i.e.,
perichondrium at this stage). (HB-GAM immunostaining, 1-wk-
old rat, humeral head.) (b) Bone of the early postnatal life con-
sists of woven bone that is formed during prenatal life and the
lamellar bone that has replaced the woven bone. The rectangle is
magnified in d (HB-GAM immunostaining, 3-wk-old rat, calca-
neal bone). (c) HeidenhainÕs AZAN staining (Gabe, 1976) of the
cortical bone of the same specimen to distinguish the woven bone
(wb) from the lamellar bone (lb). (d) The osteocytes of the lamel-
lar bone selectively express HB-GAM, whereas those of the wo-
ven bone do not. (e) HB-GAM is localized in the matrix sur-
rounding the osteocytes (double arrows), in the canaliculi of the
osteocytes (arrow), and on the bone surface (arrowhead). Bars:
(b) 500 mm; (e) 60 mm.Imai et al. HB-GAM/N-Syndecan Interaction in Bone Formation 1119
mineralization on day 21 (Fig. 5, n and o) and completely
disappeared on day 28 (data not shown). During the adult
periosteal ossification, HB-GAM was thus initially upreg-
ulated by the osteocytes within the damaged bone and was
distributed to the bone surface to which newly induced os-
teoblasts are recruited. In turn, N-syndecan was expressed
in the thickened periosteum, presumably by the osteo-
blast/osteoblast precursors that are recruited to participate
in the thickening of the periosteum.
Electron-microscopic Characterization of
N-SyndecanÐexpressing Cells
To identify the cell types that express N-syndecan during
Figure 3.( A) Transfilter hap-
totactic assay. (a) The lower
surface of the Transwell¨ fil-
ter (polycarbonate plastic)
was coated with HB-GAM,
and the cells that migrated
from the upper chamber to
the lower chamber were stud-
ied under microscopy. (b) Af-
ter the migration, the number
of cells that migrated to the
lower surface was calculated.
(c) The osteoblast-type cells
(rat osteoblast-type cells
UMR-106, and human osteo-
blast-type cells, Saos-2, U-2
and KHOS/NP) migrated
through the pores. Less than
1% of the plated osteoblast-
type cells migrated to the con-
trol matrices (nonspecific rat
IgG, 0.92%; bovine serum al-
bumin, 0.89%). All the osteo-
blast-like cells migrated in a
dose-dependent manner, but
nonosteoblastic cells, 3T3 fi-
broblasts and N18 neuroblas-
toma cells, did not respond to
HB-GAM. (B) Northern blot
analysis of the rat osteoblastic
cell line, UMR-106. N-synde-
can mRNA is seen at a similar
or even higher level as com-
pared with that of the perina-
tal rat brain. No expression is
seen in the control cells (N18
and 3T3 cells). (C) HB-GAMÐ
binding fractions isolated
from UMR-106 cells and rat
perinatal brain, and Western
blot analysis of the fractions.
Lane  1, HB-GAMÐbinding
fraction derived from the
brain; lane 2, the brain-derived
fraction treated with nitrous
acid; lane 3, the major HB-
GAMÐbinding fraction from
UMR-106 eluted at 0.5 M
NaCl in the salt gradient; lane
4, the UMR-106Ðderived frac-
tion treated with nitrous acid.
The HB-GAMÐbinding fractions isolated from UMR-106 cells have a molecular mass similar to those derived from the rat perinatal
brain. Lanes 5 and 6, Western blot using affinity-purified antibodies that bind to NH2-terminal peptide of N-syndecan. The samples in
lanes 3 and 4 are identified as N-syndecan. (D) Immunocytochemistry of N-syndecan in the UMR-106 cells. (a) N-syndecan of UMR-
106 cells is immunostained (arrowheads). (b) Trypsin treatment clearly abolishes the immunostaining. (E) Inhibition of HB-GAMÐ
induced recruitment of UMR-106 cells. (a) Recruitment of UMR-106 cells using 10 mg/ml HB-GAM is dose-dependently inhibited by
adding soluble HB-GAM or N-syndecan to the cell suspension. (b) Addition of herbimycin A, a general inhibitor for tyrosine kinases,
and PP1, a recently defined specific inhibitor for src-type tyrosine kinases, clearly interferes the cell recruitment induced by HB-GAM.The Journal of Cell Biology, Volume 143, 1998 1120
the adult periosteal ossification, a detailed electron-micro-
scopical study was performed. Fully differentiated osteo-
blasts covering the surface of healthy adult bone (Fig. 5 c,
rectangle) did not express N-syndecan (Fig. 6 a). Interest-
ingly, the osteoblasts were not found on the surface of the
damaged bone 7 d after adjuvant inoculation (day 7; Fig. 5
f, rectangle). Instead, numerous spindle-shaped cells and
their cell processes, which may represent fibroblastic os-
teoprogenitor, were noted along the bone surface. How-
ever, these cells were not immunoreactive to N-syndecan
(Fig. 6 b).
On day 10, numerous spindle-shaped cells with long
slender cell processes were noted in the vicinity of the
damaged bone (Fig. 5 i, rectangle). These spindle-shaped
cells expressed N-syndecan on their cell surface (Fig. 6 c).
Since osteoblast later expresses N-syndecan (see below),
these N-syndecanÐexpressing spindle-shaped cells may
represent preosteoblast, a presumptive motile precursor of
osteoblast. On day 14, the thickened periosteum (Fig. 5 l,
rectangle) contained numerous osteoblasts with rich rough
ER and Golgi apparatus. Osteoblasts expressed N-synde-
can on their cell surface (Fig. 6 d).
At mineralization stage on day 21, the thickened perios-
teum contained numerous osteocyte-like cells being sur-
rounded by the osteoid matrix that they produced them-
selves (Fig. 5 o, rectangle). These osteocyte-like cells had
not yet developed typical gap junctions with neighboring
cells. Some of the osteocyte-like cells retained immunore-
activity to N-syndecan (Fig. 6 e). On day 28, the ossified
matrix contains only osteocytes (i.e., the terminal differen-
tiation stage of the osteoblast lineage), and these cells did
not express N-syndecan (Fig. 6 f). These results suggest
that osteoblast lineage cells express N-syndecan when the
cells are motile.
HB-GAM Expression in the Transgenic Mice
12 transgenic founders were produced using the HB-GAM
cDNA under a b-actin promoter (Fig. 7 A). Southern blot-
ting and PCR were used to verify integration of the
construct to genomic DNA of the founders and the first
generation offspring. PCR analysis indicated that the
transgene was steadily transmitted to the next generations
in a Mendelian fashion (data not shown).
A preliminary study on the HB-GAM transgene expres-
sion in different tissues (brain, heart, femoral muscle,
liver, and kidney) was carried out by Western blotting.
Pups of three lines were found to express the transgene in
heart and skeletal muscle, whereas little if any overexpres-
sion was detected in liver, kidney, or brain (Fig. 7 B, a).
These three mice lines displaying a mesenchymal expres-
sion of the transgene were selected and propagated for
further analysis. The littermates genotyped as transgene
negative did not express HB-GAM in any of the mesen-
chymal tissues analyzed shortly after birth (Fig. 7 B, a).
The highest protein concentration due to the HB-GAM
transgene was seen in the periosteum of adult mice with a
somewhat lower expression in the heart (Fig. 7 B, b). No
expression could be detected in the periosteum of the
transgene-negative individuals from the same litter. Esti-
mated from the band intensities of Western blotting (Fig. 7
B,  b),  z50  mg/g (wet tissue weight) of HB-GAM was
found in the periosteum of the transgene-positive adults.
This amount is comparable to the highest expression levels
found in developing brain (Rauvala, 1989).
Bone Phenotype of the HB-GAM Transgenic Mice
The transgenic mice were normal at birth. However, a dis-
tinct macroscopic abnormality of bone became evident in
Figure 4. Recruitment of UMR-106 cells using the pattern of
UV-irradiated and intact HB-GAM. (a) A schematic representa-
tion of the experiment. The substrate is first coated with HB-GAM,
covered with a conventional EM grid, and irradiated with UV
that denatures the uncovered HB-GAM. (b) Cells are evenly
plated, and there is no apparent migration 30 min after plating
the cells. (c) Cells migrating from the denatured HB-GAM to the
intact HB-GAM at 3 h after plating. (d) The cells have migrated
and spread on the intact HB-GAM at 7 h after plating.Imai et al. HB-GAM/N-Syndecan Interaction in Bone Formation 1121
the transgenic mice by 12 mo of age. Bones from the
transgene-positive mice displayed an ivory-like solid sur-
face (Fig. 7 C). In contrast, the bones from the transgene-
negative mice displayed a brownish granular appearance
with some marrow structures seen through the cortical
bone (Fig. 7 C). The shape of the bones was almost normal
by macroscopic observation, but a detailed measurement
of the bone sizes suggested an enlarged diameter at the
metaphysis (Table I). Similar changes were observed among
all individuals from the three different transgene-positive
lines (n 5 3). Other tissues did not exhibit any macro-
scopic changes. Adult individuals propagated from the
transgene-positive lines and their nontransgenic litter-
mates were used for further analyses of the bone pheno-
type.
In the transgene-positive mice, HB-GAM was abun-
dantly expressed by the osteocytes dispersed in the corti-
cal bone (Fig. 8 A, c). HB-GAM was localized along the
surface of the cortical bone (Fig. 8 A, a) in a similar man-
ner to that found during the adult periosteal ossification
(see Fig. 5 h). It thus appears that HB-GAM is localized
because of binding sites on the bone surface, which may
stabilize the secreted protein and present it in a surface-
bound form to the motile osteoblasts/osteoblast precur-
sors. In contrast, the transgene-negative mice were devoid
of HB-GAM expression (Fig. 8 A, d) with the exception of
the epiphyseal growth plate (Fig. 8 A, b).
Measurement of bone sizes revealed that the major sig-
nificant difference was the increased thickness of the corti-
cal bone (Table I). This was in agreement with the macro-
scopic appearance of the transgenic mice bone (Fig. 7 C).
Thickness of the cortical bone was increased up to 147.4%
for the humerus and 124.2% for the femur by 1 yr of age.
Histomorphometric analysis showed that the cortical bone
volume (Fig. 8 B, a) and the cancellous bone volume (Fig.
8 B, b) were significantly increased in the transgene-posi-
tive mice. Bone marrow area, another parameter that is a
good indicator of osteoclast function (Fig. 8 B, c) (Parfitt,
1987), was not altered. Osteoblast surface (ObS/BS,%) of
the transgenic mice, an indicator of the number of osteo-
blasts covering the bone surface (Parfitt, 1987), was 17.2 6
4.4 as compared with 13.4 6 5.9 in the nontransgeic mice.
Figure 5. Accelerated peri-
osteal ossification after ar-
thritic damage. (a) Normal
adult rat bone. The rectangle
corresponds to b and c. (b)
HB-GAM expression is
hardly seen in the healthy
adult bone. (The magnifica-
tion for the rest of HB-GAM
immunostaining is the same.)
(c) No N-syndecan expres-
sion is observed in the
healthy adult bone. (The
magnification is the same for
the rest of N-syndecan im-
munostaining.) (d) Electron-
microscopical localization of
HB-GAM in the osteocytic
lacunae (arrowheads) at day
7. oc, osteocyte. (e) An in-
crease in the number of
HB-GAMÐexpressing osteo-
cytes at day 7 (arrowhead).
(f) No expression of N-syn-
decan at day 7. (g) Electron-
microscopical localization of
HB-GAM in the osteocytic
canaliculi (arrowheads) adja-
cent to the damaged bone
surface at day 10. (h) The
surface of the damaged bone
becomes immunoreactive to
HB-GAM (arrowhead) at
day 10. (i) N-syndecan is
noted for the first time at day
10 (arrowhead). (j) The periosteum is thickened at day 14. The rectangle corresponds to k and l. (k) The thickened periosteum is abun-
dant in HB-GAM (asterisks) at day 14. (l) N-syndecan expression similar to the expression of HB-GAM (asterisks) at day 14. (m) The
thickened periosteum is mineralized at day 21. The rectangle corresponds to n and o. (n) HB-GAM expression disappears from the min-
eralized bone at day 21. (o) N-syndecan is downregulated at day 21. The rectangles in c, f, i, l, and o correspond to Fig. 5, aÐe, respec-
tively. cb, width of cortical bone; tp, width of thickened periosteum; mb, width of mineralized bone. Bars: (a, j, and m) 1,000 mm; (b and c)
100 mm; (d) 2.8 mm; (g) 4 mm.The Journal of Cell Biology, Volume 143, 1998 1122
Discussion
Expression of HB-GAM and N-Syndecan in Developing 
and Regenerating Bone
Endochondral bone formation is a complex series of se-
quential biological events involving template formation by
the cartilage, mineralization of the cartilage, resorption of
the mineralized cartilage, and finally replacement by bone
(Marks and Hermey, 1996). Strictly speaking, the mineral-
ized cartilage is partially resorbed by osteoclasts and mac-
rophages, which create channels for recruitment of osteo-
blast precursors but leave some struts of the cartilage
intact. These cartilage struts act as an osteoconductive
substrate, permitting the osteoblast precursors to attach
and initiate deposition of osteoid (Marks and Hermey,
1996; Scammell and Roach, 1996).
Our study on the developing rat bone demonstrates that
HB-GAM is strongly expressed in the cartilage template
(Fig. 1 a). HB-GAM persists in the mineralized cartilage
(Fig. 1 c, arrowheads), onto which the osteoblast precur-
sors are recruited (Marks and Hermey, 1996; Scammell
and Roach, 1996). This finding is in agreement with the
very recent report addressing the expression of HB-GAM
during chicken embryogenesis (Dreyfus et al., 1998). In
turn, N-syndecan is expressed by a group of cells dispersed
between the struts of the mineralized cartilage (Fig. 1, d, f,
and g). Ultrastructural phenotypes of the N-syndecanÐ
expressing cells are suggestive of an active cell motility
(Fig. 1 h). These observations lead us to hypotheses that
(a) N-syndecan may be expressed by the motile precursors
of osteoblasts; (b) HB-GAM may be expressed in the ma-
trices of their destination; and (c) HB-GAM/N-syndecan
Figure 6. Electron-micro-
scopic characterization of
N-syndecanÐexpressing cells.
(a) N-syndecan is not ex-
pressed by any cell types of
the healthy adult bone (oc,
osteocyte; ob, osteoblasts; fb,
fibroblast-like cell). (b) N-syn-
decan is not expressed by the
cellular components along
the bone surface of 7 d after
adjuvant inoculation (day 7).
The bone surface is cha-
racterized by numerous spin-
dle-shaped small cells (diam-
eter  5  2Ð3  mm;  double
arrowheads), cell processes
of these cells (arrowheads),
and long cell processes ex-
tending from the osteocytes
(arrow). (c) N-syndecan is
detected for the first time at
day 10 (arrows). N-syndecan
is expressed on the spindle-
shaped small cells (arrow, di-
ameter of the cells 5 2Ð3
mm) and on their long slen-
der cell processes (double ar-
rowheads). (d) N-syndecan
is expressed (arrow) by the
osteoblast-like cells (ob-l)
characterized by cuboid-
shaped large cell soma (di-
ameter  5  8Ð12  mm), rich
rough ER (1), and Golgi ap-
paratus (asterisk) at day 14.
(e) N-syndecan expression
remaining on the cell surface
of osteocyte-like cells (oc-l)
characterized by lens-shaped
small cell soma at day 21 (di-
ameter of the cells 5 3Ð4
mm). These cells have not yet developed gap junctions with the neighboring cells (asterisk), a typical feature of fully differentiated osteo-
cytes. (f) N-syndecan is not expressed by the fully differentiated osteocytes characterized by satellite-shaped cell soma with the cell pro-
cesses radiating into the mineralized bone matrix at day 28 (arrows). The rectangles in cÐe indicate the insets. Bars: (a) 4 mm; (b) 2.3 mm;
(c) 2 mm; (d) 1.9 mm; (e) 2.6 mm; (f) 3.2 mm.Imai et al. HB-GAM/N-Syndecan Interaction in Bone Formation 1123
interaction may participate in osteoblast recruitment and
attachment to their target substrates in addition to the
chemotactic signals provided by the diffusible factors
(Bonewald, 1996).
Localization of HB-GAM can also be seen in the carti-
lage matrices of the epiphyseal growth plate (Fig. 8 A, a
and b, arrowheads) and the secondary ossification center
(Fig. 2 a), on the bone surface of the growing lamellar
bone (Fig. 2 e), and in the head epithelia of the developing
skull (Mitsiadis et al., 1995). All of these anatomical re-
gions are known to be the sites where osteoblast precur-
sors are recruited for deposition of osteoid. Osteoblasts/
osteoblast precursors are thought to be brought into the
vicinity of the target matrices, presumably via the chemo-
tactic effects of the diffusible factors (Bonewald, 1996).
However, little is understood about how these cells are
thereafter informed where to deposit the osteoid. Accu-
rate guidance of axonal outgrowth, which is a particular
form of cell motility, has been shown for several matrix-
associated guiding molecules (Baier and Bonhoeffer,
1992). It is thus possible that the osteoblast precursors, af-
ter being brought into the vicinity of their target matrices,
use a contact-dependent signal to find their destination
should they express a functional receptor for the signal.
N-syndecan expressed by the osteoblasts/osteoblast pre-
cursors may act as a receptor for HB-GAM to guide the
migration of these cells to their target substrate.
Osteoblast Recruitment Induced by HB-GAM
To test the hypothetical osteoblast recruitment mediated
by HB-GAM, we used several osteoblast-type cells (i.e.,
osteogenic sarcoma cell lines), including rat osteoblast-
type cells, UMR-106, and human osteoblast-type cells,
Saos-2, U-2 OS, and KHOS/NP. These cells are shown to
migrate rapidly to HB-GAM in a dose-dependent manner,
whereas nonosteoblastic cells, N18 and 3T3 cells, do not
respond to HB-GAM (Fig. 3 A).
Figure 7.( A) Schematic dia-
gram of the gene construct
used to produce transgenic
mice. HB-GAM cDNA was
cloned in the pHBApr-1-neo
vector, which contains the
promoter and the first intron
from human b-actin gene and
SV-40 polyadenylation signal.
(B) Expression of HB-GAM
in transgenic mice. (a) West-
ern blot analysis of different
neonatal tissues (postnatal
day 1) from a transgene-posi-
tive mouse (lanes noted by
1) and its transgene-negative
littermate (noted by 2). Lane
b, brain; lane h, heart; lane m,
femoral muscle; lane l, liver;
lane k, kidney. Note the in-
tense transgene expression
in heart and muscle. (b)
Transgene expression in the
periosteum in comparison to
the heart of 1-yr-old mice.
Western blot analysis of tis-
sues from two different trans-
genic lines (noted by 1) and
their nontransgenic litter-
mates (noted by 2). HB-
GAM expression in the
transgenic periosteum (p) is
even higher than that in the
heart (h). Lane c, control re-
combinant HB-GAM protein
(100 ng). (C) Gross appear-
ance of bones form a 1-yr-old
transgene-positive mouse
(left in all panels) and those from its transgene-negative littermate (right). (a) Femora of transgene-positive (Tg) and transgene-negative
(Non-tg) mice. Note the ivory-like solid appearance of the transgene-positive femur, whereas the transgene-negative femur displays a
brownish surface because of the bone marrow structures that are seen through the thin cortical bone (arrow). (b) Ulnae. Brownish mar-
row structure is also seen in the transgene-negative ulna (arrow). (c) Scapulae (1) and humeri (2). The ivory-like appearance is particu-
larly prominent in the scapular spinus of the transgene-positive mouse (arrow). Note the transparency of scapular plane in the trans-
gene-negative bone (arrowhead).The Journal of Cell Biology, Volume 143, 1998 1124
To further investigate how the osteoblast-type cells re-
spond to HB-GAM, whereas the nonosteoblast-type cells
do not, we studied UMR-106 cells in more detail. Based
upon the profiles of osteoblastic characteristics and mor-
phological features that are similar to osteoblast lineage
cells in vivo, UMR-106 cells have been considered as preo-
steoblasts, the immediate precursor of the fully differenti-
ated osteoblast (Rodan and Noda, 1991). UMR-106 cells
are known to express N-syndecan as abundantly as, or
even more abundantly than, the developing brain (Fig. 3.
B and D), which has been the only known source of N-syn-
decan (Carey et al., 1992). N-syndecan is also isolated
from crude extracts of UMR-106 cells by HB-GAM affin-
ity column (Fig. 3 B).
The control cells (N18 and 3T3 cells), which did not re-
spond to HB-GAM, were shown to be N-syndecan nega-
tive (Fig. 3 A, c). The migration of the osteoblast-type cells
in the transfilter assays cannot be explained by random
migration of the cells because more than 90% of the
plated cells migrate to the lower surface when HB-GAM
is coated at 50 mg/ml. In addition, the recruitment of the
cells does not depend on the nonspecific adhesiveness pro-
vided by the polycationic property of HB-GAM, but de-
pends on the intact molecular structure of HB-GAM (Fig.
4). Furthermore, the recruitment of UMR-106 cells is
likely to depend on the interaction of the cell surface
N-syndecan and substrate-bound HB-GAM since the mi-
gration can be competed by addition of either soluble
N-syndecan or soluble HB-GAM (Fig. 3 E, a). Further
studies are required to show whether the receptor-type
protein-tyrosine phosphatase-u/b plays a role in HB-GAMÐ
induced osteoblast migration in addition to N-syndecan, as
it is suggested for the HB-GAMÐinduced migratory re-
sponse in neurons (Maeda et al., 1996).
Cell surface proteoglycans have been regarded as mere
storage sites for growth factors or as coreceptors in growth
factor signaling but have not been generally considered
functional receptors that can directly activate cytosolic
signaling pathways. The cytosolic domain of N-syndecan
binds a protein complex containing src-family tyrosine
kinases (pp60-src and fyn) and the src-substrate cortactin
(T. Kinnunen et al., 1998). Binding of HB-GAM to N-syn-
decan leads to phosphorylation and activation of src fol-
lowed by cortactin phosphorylation (T. Kinnunen et al.,
1998). Phosphorylation of cortactin is known to modulate
its F-actin cross-linking activity (Hung et al., 1997) and
probably contributes to the cell motility (T. Kinnunen et al.,
1998). Since the specific inhibitor of src-family kinases,
PP1 (Hanke et al., 1996), clearly impairs the recruitment
of UMR-106 cells (Fig. 3 E, b), the cytoskeletal reorgani-
zation via src-dependent phosphorylation is likely to play
a role in the HB-GAMÐinduced osteoblast recruitment.
Furthermore, methods that have been applied to study
N-syndecanÐmediated signaling in neurons (T. Kinnunen et
al., 1998) have been very recently used to study the intra-
cellular interactions of N-syndecan in the UMR-106 cells.
These studies have shown that the cytosolic moiety of
N-syndecan interacts with a tyrosine kinaseÐactive protein
complex containing cortactin in the UMR-106 cells (Kin-
nunen, T., S. Imai, and H. Rauvala, unpublished results).
These results agree with the inhibition of osteoblast migra-
tion by PP1. Thus, also from the viewpoint of the intracel-
lular signaling mechanism, it has been suggested that the
HB-GAMÐinduced osteoblast migration is similar to the
HB-GAMÐinduced migratory response in neurons.
The experimental design using the Transwell¨ chamber
may require an explanation for the corresponding in vivo
condition. The osteoblast-type cells must have extended
their cell processes to interact with the HB-GAM mole-
cule immobilized on the lower surface (Fig. 3 A, a). In fact,
N-syndecanÐexpressing cells in vivo are characterized by
the long slender cell processes that may explore their sur-
rounding substrates (Fig. 6 c). The lengths of the processes
well exceed 15 mm, which is the depth of the pore in the
filter (Fig. 3 D, a). After the induced osteoblast precursors
are brought into the vicinity of the target matrices, these
cells may respond to HB-GAM with their long cell pro-
cesses that express N-syndecan.
While much is known about the kinetics of bone turn-
over, little is understood about the coordinated regulation
of bone deposition and resorption at molecular level
(Canalis et al., 1991). The Ònerve cellÓ role of osteocytes
has been long debated for its anatomical and cell biologi-
cal characteristics (Nijweide et al., 1996). Osteocytes are
dispersed throughout the mineralized bone and are con-
nected with their neighboring osteocytes via long cell pro-
cesses that form a nerve-like network within the bone.
Their processes connect with each other via gap junctions
(Doty, 1981), thereby allowing cell-to-cell coupling (Jean-
sonne et al., 1979). The matrix around their processes is
permeable to macromolecules (Dillaman et al., 1991),
thereby allowing rapid passage of the yet unidentified sig-
nal molecules through the canaliculi (Nijweide et al.,
1996). Elevation of metabolic (Pead et al., 1988; Skerry et al.,
1989) and endocrine activities (Lean et al., 1995) after me-
chanical or electrical stimulation has predicted a role of
osteocytes as a local regulator of bone formation. It is par-
Table I. Sizes of the Femur and Humerus from Transgenic and 
Nontransgenic Mice
Parameter Nontransgenicà Transgenicà P value*
Femur
Longitudinal length 13,335 6 486 13,751 6 548 0.0755
Diaphysis
Diameter 1,032 6 240 1,099 6 199 0.2829
Thickness 190 6 32 236 6 49 0.0186
Metaphysis
Diameter 1,029 6 298 1,131 6 238 0.2373
Thickness 143 6 40 194 6 54 0.0237
Humerus
Longitudinal length 11,000 6 206 11,431 6 415 0.0010
Diaphysis
Diameter 1,279 6 152 1,158 6 170 0.0801
Thickness 196 6 27 289 6 40 0.0005
Metaphysis
Diameter 1,182 6 325 1,247 6 259 0.0337
Thickness 164 6 64 197 6 76 0.1834
Thickness describes thickness of the cortical bone. Parameters for diaphysis are mea-
sured at the midpoint of longitudinal length, and those for metaphysis are measured at
one quarter of the longitudinal length apart from either humeral or femoral head. Sizes
are in micrometers (mean 6 SEM).
*StudentÕs t test.
àNumber of animals for nontransgenic and their transgenic littermates were 7 and 9,
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ticularly interesting that the osteocytes upregulate HB-
GAM production during an accelerated periosteal ossifi-
cation (Fig. 5 e) and localize it on the bone surface during
recruitment of the osteoblasts (Fig. 5, h and k). By localiz-
ing HB-GAM via bone canaliculi, the osteocytes may pre-
pare the bone surface as a substrate for the appositional
ossification. The prepared bone surface may act as an os-
teoconductive substrate in a similar sense to that of the
mineralized cartilage (see Fig. 1 c).
Detailed ultrastructural characterization suggests that
N-syndecan is expressed by several groups of bone form-
ing cells, i.e., by osteoblast-like cells (Fig. 6 d) and later by
osteocyte-like cells (Fig. 6 e). This is in a clear contrast to
the finding that the differentiated osteoblasts covering the
healthy bone surface do not express N-syndecan (Fig. 6 a).
It must be remembered that these osteoid-producing os-
teoblasts are not motile. In turn, expression of N-syndecan
seems to depend on the motility of the osteoblast lineage
cells. Its expression is the most intense in the spindle-
shaped cells with the long slender cell processes (Fig. 6 c),
weaker in the osteoblast-like cells (Fig. 6 d), and faint in
the osteocyte-like cells (Fig. 6 e). N-syndecan completely
disappears from the mature osteocytes, the immobile ter-
minal differentiation stage of the osteoblast lineage (Fig. 6 f).
Enhanced Bone Formation in Transgenic Mice
The hypothesis that HB-GAM regulates bone formation is
tested by producing the transgenic mice that maintain an
elevated level of HB-GAM on their bone surface. First of
all, it should be noted that these mice display no develop-
mental anomaly at birth. This is probably due to the high
expression level of endogenous HB-GAM during embry-
onic development. The high expression level is likely to
override the effect of the transgene. The high expression
level is maintained also during the postnatal growth of
bone, where HB-GAM is localized on bone surface with
the osteocytes being its cellular source (Fig. 2 e). After
skeletal maturity, however, the expression of HB-GAM is
normally downregulated (Fig. 8 A, b and d; also see Fig. 5 b).
Figure 8.( A) Bone phenotype of the HB-GAM
transgenic mice. Femora from 1-yr-old trans-
genic (a and c) and nontransgenic (b and d) lit-
termates. (a) HB-GAM is abundantly expressed
by osteocytes of the transgene-positive femur,
and it is widely distributed along the bone sur-
face (arrows). (b) HB-GAM expression in the
transgene-negative femur is confined to the epi-
physeal growth plate (arrowheads), which per-
sists throughout life in rodents. Note that the
transgene-positive mouse (a) has developed a
much wider growth plate (arrowheads). (c)
HB-GAM is expressed in the transgene-positive
femur by the osteocytes of cortical bone (arrow-
heads) and localized to the bone surface (arrows)
in a similar manner to that found during regener-
ation (see Fig. 4 h). (d) HB-GAM is not ex-
pressed either by the osteocytes or on the bone
surface (arrow) in the transgene-negative femur.
The cortical bone of the transgene-positive fe-
mur (cb9 in c) is much thicker than that of the
transgene-negative femur (cb in d). (B) Histo-
morphometric analysis of femora of transgene-
negative (Non tg) and transgene-positive mice
(Tg). The parameters followed the recom-
mended nomenclature (Parfitt et al., 1987). (a)
Cortical bone volume (BT/TV,%): expressed as
the percentage of the cortical tissue area divided
by the cross-sectional area. (b) Cancellous bone
volume (BT/TV,%): expressed as the percentage
of metaphyseal area occupied by cancellous bone
excluding the cortices. (c) Bone marrow space
(mm2): area of metaphyseal marrow cavity ex-
cluding cancellous bone. Bars represent means 6
SEM. Statistical differences between the groups
were assessed by StudentÕs t test (*P , 0.05,
**P , 0.01, n 5 6 and 8 for nontransgenic and
transgenic mice, respectively).The Journal of Cell Biology, Volume 143, 1998 1126
The transgenic mice, in turn, maintain an elevated level
of HB-GAM even at the age of 12 mo (Fig. 7 B, b), and
the localization of HB-GAM on the bone surface is similar
to that of the postnatal bone growth (Fig. 8 A, a and c, see
also Fig. 2, d and e) and that of the postarthritic periosteal
ossification (Fig. 5 h). The transgenic mice develop a dis-
tinct bone phenotype characterized by an increased vol-
ume of the cortical and cancellous bone. This finding is
compatible with the finding that local HB-GAM antago-
nizes bone mineral loss induced by estrogen deprivation
(Matsuda et al., 1997).
The mechanism of the increased bone formation is not
likely to be due to the decreased osteoclastic function
since the bone marrow space, a good indicator of osteo-
clastic function (Parfitt, 1987), is not altered. Addition of
HB-GAM to osteoblast-type cells has been shown to re-
sult in a 1.6Ð2.0-fold increase in the alkaline phosphatase
activity and a 1.2Ð1.8-fold increase in the DNA content
(Zhou et al., 1992). Since magnitudes of these effects are
rather modest as compared with those of other growth and
differentiation factors, the osteoblast-stimulating action of
HB-GAM has received little attention. However, the pre-
sent study demonstrates a prominent osteoblast-recruiting
action of HB-GAM, and the N-syndecan expression by the
osteoblasts/osteoblast precursors also supports this.
HB-GAM transgene may thus lead to the increased bone
volume by not only recruiting the osteoblasts to the bone
surface but also by maintaining the osteoblastic activity of
the recruited osteoblasts.
A Model of HB-GAM Function in Bone Development 
and Repair
The hypothetical osteoblast recruitment mediated by
HB-GAM explains well the yet unclear mechanism of os-
teoblast recruitment and attachment to the different target
substrates. It is particularly noteworthy that different cell
types act as the source of HB-GAM, e.g., chondrocytes
during prenatal endochondral ossification, osteocytes of
the lamellar bone during postnatal bone growth, and os-
teocytes of the injured bone during postarthritic ossifica-
tion.
Induction of osteoblasts has been attributed to a variety
of growth and differentiation factors (Rosen and Thies,
1992; Kingsley, 1994; Bonewald, 1996), but the induced os-
teoblasts must be precisely located to form an appropriate
shape and mass of future bone. In addition, bone is a self-
organizational organ that alters its shape and mass accord-
ing to the physical and chemical environments around
bone itself.
HB-GAM is upregulated on the surface of damaged
bone, where recruited osteoblasts deposit new osteoid for
repair process (Fig. 5). The growth and differentiation fac-
tors responsible for the osteoblast induction are probably
induced in the environment of the damaged bone. These
factors may also act on the damaged bone so that the dam-
aged bone surface may be marked with HB-GAM (Fig. 9).
Although HB-GAM gene expression has been shown to
be induced by platelet-derived growth factor in vitro (Li
Figure 9. A model for the
HB-GAM/N-syndecan inter-
action in regulation of osteo-
blast recruitment and attach-
ment to the sites for new
bone deposition.Imai et al. HB-GAM/N-Syndecan Interaction in Bone Formation 1127
et al., 1992), other factors involved in bone repair may also
act for the HB-GAM induction in situ. This model suits
well the yet unclear mechanism of the self-organizational
control of bone formation. The osteoblasts further differ-
entiate to osteocytes being surrounded by the osteoid ma-
trix that they produce, and they then may become a new
source of HB-GAM for the next round of osteoblast re-
cruitment (Fig. 9). A future application of HB-GAM may
contribute to the clinically desired bone formation, which
has not been fully attained by application of other growth
and differentiation factors.
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